📖
Dried blood spot IP-10 as a biomarker of tuberculosis severity and treatment responses: results from a phase IIb trial of adjunctive acetylsalicylic acid and ibuprofen.
Høgbakk Edlund I, Alonso-Rodriguez N, Sopegno C, Farrés J, Gogichadze N, Arias L, Fonseca KL, Otwombe K, Waja Z, Moloantoa T, Pillay N, Seiphetlo T, Martinson N, Vilaplana C, Dyrhol-Riise AM

Dried blood spot IP-10 as a biomarker of tuberculosis severity and treatment responses: results from a phase IIb trial of adjunctive acetylsalicylic acid and ibuprofen.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Front Immunol.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Dried blood spot IP-10 as a biomarker of tuberculosis severity and treatment responses: results from a phase IIb trial of adjunctive acetylsalicylic acid and ibuprofen.
Author / Organization Høgbakk Edlund I, Alonso-Rodriguez N, Sopegno C, Farrés J, Gogichadze N, Arias L, Fonseca KL, Otwombe K, Waja Z, Moloantoa T, Pillay N, Seiphetlo T, Martinson N, Vilaplana C, Dyrhol-Riise AM
Subject & Discipline Front Immunol
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-120706
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »